A detailed history of Assetmark, Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Assetmark, Inc holds 150,509 shares of ABBV stock, worth $30.2 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
150,509
Previous 138,616 8.58%
Holding current value
$30.2 Million
Previous $23.8 Million 25.01%
% of portfolio
0.09%
Previous 0.07%

Shares

36 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$163.84 - $199.33 $1.95 Million - $2.37 Million
11,893 Added 8.58%
150,509 $29.7 Million
Q2 2024

Aug 13, 2024

BUY
$154.79 - $180.76 $759,399 - $886,808
4,906 Added 3.67%
138,616 $23.8 Million
Q1 2024

May 06, 2024

BUY
$159.82 - $182.1 $521,492 - $594,192
3,263 Added 2.5%
133,710 $24.3 Million
Q4 2023

Feb 09, 2024

BUY
$137.6 - $154.97 $915,865 - $1.03 Million
6,656 Added 5.38%
130,447 $20.2 Million
Q3 2023

Oct 27, 2023

BUY
$133.59 - $154.65 $193,304 - $223,778
1,447 Added 1.18%
123,791 $18.5 Million
Q2 2023

Aug 11, 2023

BUY
$132.51 - $164.9 $198,499 - $247,020
1,498 Added 1.24%
122,344 $16.5 Million
Q1 2023

May 05, 2023

BUY
$144.61 - $166.54 $905,547 - $1.04 Million
6,262 Added 5.46%
120,846 $19.3 Million
Q4 2022

Feb 10, 2023

BUY
$138.31 - $165.87 $1.67 Million - $2 Million
12,083 Added 11.79%
114,584 $18.5 Million
Q3 2022

Nov 01, 2022

BUY
$134.21 - $153.93 $793,315 - $909,880
5,911 Added 6.12%
102,501 $13.8 Million
Q2 2022

Aug 03, 2022

BUY
$137.62 - $174.96 $668,833 - $850,305
4,860 Added 5.3%
96,590 $14.8 Million
Q1 2022

May 13, 2022

SELL
$131.98 - $163.75 $2.87 Million - $3.57 Million
-21,776 Reduced 19.18%
91,730 $14.9 Million
Q4 2021

Feb 14, 2022

SELL
$107.43 - $135.93 $17,511 - $22,156
-163 Reduced 0.14%
113,506 $15.4 Million
Q3 2021

Nov 12, 2021

BUY
$106.4 - $120.78 $209,076 - $237,332
1,965 Added 1.76%
113,669 $12.3 Million
Q2 2021

Aug 16, 2021

SELL
$105.21 - $117.21 $6.08 Million - $6.78 Million
-57,803 Reduced 34.1%
111,704 $12.6 Million
Q1 2021

May 14, 2021

SELL
$102.3 - $112.62 $39,897 - $43,921
-390 Reduced 0.23%
169,507 $18.3 Million
Q4 2020

Feb 10, 2021

SELL
$80.49 - $108.67 $5.49 Million - $7.41 Million
-68,192 Reduced 28.64%
169,897 $18.2 Million
Q3 2020

Nov 13, 2020

BUY
$85.91 - $100.83 $7.81 Million - $9.17 Million
90,918 Added 61.78%
238,089 $20.9 Million
Q2 2020

Aug 11, 2020

SELL
$73.37 - $98.18 $707,213 - $946,357
-9,639 Reduced 6.15%
147,171 $14 Million
Q1 2020

May 12, 2020

SELL
$64.5 - $97.79 $162,088 - $245,746
-2,513 Reduced 1.58%
156,810 $11.9 Million
Q4 2019

Feb 11, 2020

BUY
$72.13 - $90.25 $6.24 Million - $7.81 Million
86,524 Added 118.85%
159,323 $14.1 Million
Q3 2019

Nov 13, 2019

BUY
$62.98 - $75.72 $1.64 Million - $1.97 Million
26,027 Added 55.65%
72,799 $5.51 Million
Q2 2019

Aug 14, 2019

BUY
$65.7 - $83.98 $613,835 - $784,625
9,343 Added 24.96%
46,772 $3.4 Million
Q1 2019

May 14, 2019

BUY
$77.14 - $90.79 $213,677 - $251,488
2,770 Added 7.99%
37,429 $3.02 Million
Q4 2018

Feb 13, 2019

SELL
$77.85 - $96.01 $14.3 Million - $17.6 Million
-183,754 Reduced 84.13%
34,659 $3.2 Million
Q3 2018

Nov 13, 2018

BUY
$88.91 - $98.84 $1.55 Million - $1.73 Million
17,483 Added 8.7%
218,413 $20.7 Million
Q2 2018

Aug 01, 2018

BUY
$89.78 - $106.23 $2 Million - $2.37 Million
22,288 Added 12.48%
200,930 $18.6 Million
Q1 2018

May 16, 2018

BUY
$92.01 - $123.21 $5.86 Million - $7.85 Million
63,704 Added 55.42%
178,642 $16.9 Million
Q4 2017

Feb 13, 2018

SELL
$89.56 - $98.21 $2.3 Million - $2.52 Million
-25,654 Reduced 18.25%
114,938 $11.1 Million
Q3 2017

Nov 08, 2017

BUY
$69.85 - $89.22 $5.62 Million - $7.18 Million
80,496 Added 133.95%
140,592 $12.5 Million
Q2 2017

Aug 15, 2017

BUY
N/A
14,200 Added 30.94%
60,096 $4.36 Million
Q1 2017

Sep 15, 2017

BUY
N/A
13,304 Added 40.82%
45,896 $2.99 Million
Q4 2016

Sep 15, 2017

SELL
N/A
-183 Reduced 0.56%
32,592 $2.04 Million
Q3 2016

Sep 15, 2017

SELL
N/A
-6,713 Reduced 17.0%
32,775 $2.07 Million
Q2 2016

Sep 15, 2017

BUY
N/A
1,344 Added 3.52%
39,488 $2.45 Million
Q1 2016

Sep 15, 2017

BUY
N/A
14,231 Added 59.51%
38,144 $2.18 Million
Q4 2015

Sep 15, 2017

BUY
N/A
23,913
23,913 $1.42 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $355B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Assetmark, Inc Portfolio

Follow Assetmark, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Assetmark, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Assetmark, Inc with notifications on news.